A theoretical and spectroscopic study of γ-crystalline and amorphous indometacin

被引:70
作者
Strachan, Clare J.
Rades, Thomas
Gordon, Keith C. [1 ]
机构
[1] Univ Otago, Dept Chem, Dunedin, New Zealand
[2] Univ Otago, Sch Pharm, Dunedin, New Zealand
[3] Univ Helsinki, Div Pharmaceut Technol, Fac Pharm, Helsinki, Finland
[4] Univ Helsinki, Drug Discovery & Dev Technol Ctr, Fac Pharm, Helsinki, Finland
关键词
D O I
10.1211/jpp.59.2.0012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Amorphous materials are prevalent in the pharmaceutical setting. Whether they are a help or hindrance, their physico-chemical characteristics must be investigated. However, the amorphous form remains a challenge to characterise with many of its properties poorly understood. In this study, gamma-crystalline and amorphous indometacin are investigated using vibrational spectroscopy and quantum chemical calculations. The structure of the single indometacin molecule and the dimer in the gamma-form were optimised using density functional theory calculations. The optimised structures were similar to the conformations in the crystal form, suggesting that conformation of the molecules in the crystal may be close to the average molecular structure in less-ordered states. Infrared and Raman spectra were calculated from the optimised structures. Many modes in the calculated spectra could be matched with the experimental spectra of the gamma-crystalline and amorphous forms, and a description of the matched modes has been provided. By analysis of the theoretical vibrational modes it was confirmed that the amorphous form of indometacin produced by quench cooling the melt consists predominantly of climers, similar in structure to in the gamma-crystalline form. In addition, differences in intermolecular bonding between the two forms were identified. Quantum mechanical calculations allow improved understanding of amorphous materials and their vibrational spectra.
引用
收藏
页码:261 / 269
页数:9
相关论文
共 33 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]  
BERNSTEIN J, 2002, INT UNION CRYSTALLOG, P410
[3]  
BRITTAIN HG, 2000, POLYMORPHISM PHARM S
[4]   Thermotropic liquid crystalline drugs [J].
Bunjes, H ;
Rades, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (07) :807-816
[5]   The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state [J].
Crowley, KJ ;
Zografi, G .
PHARMACEUTICAL RESEARCH, 2003, 20 (09) :1417-1422
[6]   Cryogenic grinding of indomethacin polymorphs and solvates: Assessment of amorphous phase formation and amorphous phase physical stability [J].
Crowley, KJ ;
Zografi, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (02) :492-507
[7]   Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions [J].
Crowley, KJ ;
Zografi, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (10) :2150-2165
[8]   Ultrasound-compacted indomethacin/polyvinylpyrrolidone systems: Effect of compaction process on particle morphology and dissolution behavior [J].
Fini, A ;
Holgado, MA ;
Rodriguez, L ;
Cavallari, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (08) :1880-1890
[9]   Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis [J].
Forster, A ;
Hempenstall, J ;
Tucker, I ;
Rades, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 226 (1-2) :147-161
[10]   The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion [J].
Forster, A ;
Hempenstall, J ;
Tucker, I ;
Rades, T .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (06) :549-560